Please try another search
By Miranda Murray and Ludwig Burger (Reuters) -Swiss contract drug manufacturer Lonza said on Wednesday it would buy one of the world's largest manufacturing sites for biologic drugs in California...
ZURICH (Reuters) -Roche is cutting 345 jobs, Swiss website Muula reported, as the drugs company responds to lower profit posted for 2023 and a more cautious outlook for the year ahead. The jobs will...
By Ludwig Burger (Reuters) -Roche agreed to take over unlisted obesity drug developer Carmot Therapeutics for $2.7 billion upfront, joining a list of contestants seeking to challenge the dominant...
Sharecast - Carmot’s R&D portfolio includes clinical stage subcutaneous and oral incretins with best-in-class potential to treat obesity in patients with and without diabetes, as well as a...
By Luis Jaime Acosta BOGOTA (Reuters) -Swiss drugs and diagnostics maker Roche is investing $240 million in Colombia over five years as part of its plan to consolidate its presence in the country, a...
By Ludwig Burger and Oliver Hirt (Reuters) -Quarterly sales at Switzerland's Roche slipped 3% as a slump in COVID-19 product sales and a strong Swiss franc overshadowed the launch of a drug against...
By Ludwig Burger and Patricia Weiss FRANKFURT (Reuters) -Bayer's new CEO plans to cut management jobs to speed up decision-making as a first step to overhaul the embattled German industrial group,...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review